| scholarly article | Q13442814 |
| P2093 | author name string | Kathryn A O'Donnell | |
| Gail E Tomlinson | |||
| Robert E Hammer | |||
| Dinesh Rakheja | |||
| Yidong Chen | |||
| Milton J Finegold | |||
| Sarah A Comerford | |||
| Dolores Lopez-Terrada | |||
| Hima Bansal | |||
| Elizabeth A Hinnant | |||
| Shawn Klapproth | |||
| P2860 | cites work | Cancer genome landscapes | Q22242276 |
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Developmental context determines latency of MYC-induced tumorigenesis | Q24794847 | ||
| Strategically targeting MYC in cancer | Q26747745 | ||
| Dedifferentiation and reprogramming: origins of cancer stem cells | Q26826876 | ||
| Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium | Q26828479 | ||
| Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis | Q27478444 | ||
| Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy | Q27685461 | ||
| Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis | Q28242612 | ||
| Lineage dependency and lineage-survival oncogenes in human cancer | Q28253671 | ||
| The epidemiology of hepatoblastoma | Q28268711 | ||
| The β-catenin destruction complex | Q28279593 | ||
| Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture | Q28303776 | ||
| The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer | Q28387975 | ||
| Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance | Q28505114 | ||
| PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes | Q29547229 | ||
| Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesis | Q33344462 | ||
| Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway | Q33569956 | ||
| Gene expression analysis via multidimensional scaling. | Q51887994 | ||
| Mouse hepatoblasts at distinct developmental stages are characterized by expression of EpCAM and DLK1: drastic change of EpCAM expression during liver development. | Q51932551 | ||
| Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. | Q52065383 | ||
| Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate. | Q53326694 | ||
| Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin. | Q53391138 | ||
| Oncogene-induced liver neoplasia in transgenic mice. | Q53515079 | ||
| Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex. | Q54346071 | ||
| Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer | Q56762983 | ||
| DNA excision in liver by an albumin-Cre transgene occurs progressively with age | Q61203358 | ||
| Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos | Q69937778 | ||
| Transient expression of bile-duct-specific cytokeratin in fetal mouse hepatocytes | Q71655393 | ||
| Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin | Q73773421 | ||
| III. Intracellular signaling in response to toxic liver injury | Q77551222 | ||
| Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring aberrations involving 1q12-q21 | Q81892355 | ||
| Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour? | Q84518605 | ||
| Field cancerization in non-small cell lung cancer: implications in disease pathogenesis | Q34272221 | ||
| NRF2 and cancer: the good, the bad and the importance of context. | Q34289003 | ||
| MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer | Q34357796 | ||
| Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer | Q34377430 | ||
| Antioxidants accelerate lung cancer progression in mice | Q34400895 | ||
| Increased risk of hepatoblastoma among immature children with a lower birth weight. | Q34749769 | ||
| Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's Oncology Group | Q34871284 | ||
| Distinct thresholds govern Myc's biological output in vivo | Q34897529 | ||
| Cited1 deficiency suppresses intestinal tumorigenesis. | Q34917145 | ||
| Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets | Q36104399 | ||
| Genomic Profiling Reveals Unique Molecular Alterations in Hepatoblastomas and Adjacent Hepatocellular Carcinomas in B6C3F1 Mice. | Q36348318 | ||
| Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3. | Q36928964 | ||
| B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver | Q36999867 | ||
| The cytoprotective Nrf2 transcription factor controls insulin receptor signaling in the regenerating liver | Q37138951 | ||
| The emerging role of the Nrf2-Keap1 signaling pathway in cancer | Q37271797 | ||
| Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma | Q37284612 | ||
| Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury | Q37316489 | ||
| A novel significance score for gene selection and ranking. | Q37642326 | ||
| Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies | Q38014796 | ||
| Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture | Q38593507 | ||
| The genomic landscape of hepatoblastoma and their progenies with HCC-like features | Q38964756 | ||
| β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma | Q38993024 | ||
| Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor | Q39819929 | ||
| Cancer incidence among children and adolescents in the United States, 2001-2003. | Q40085106 | ||
| Regulation of Lef-mediated transcription and p53-dependent pathway by associating beta-catenin with CBP/p300. | Q40867085 | ||
| Comparative analysis of SV40 17kT and LT function in vivo demonstrates that LT's C-terminus re-programs hepatic gene expression and is necessary for tumorigenesis in the liver. | Q41660129 | ||
| Developmental appearance of ammonia-metabolizing enzymes in prenatal murine liver | Q41668561 | ||
| Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling. | Q42067728 | ||
| Trans-ancestry mutational landscape of hepatocellular carcinoma genomes | Q42182370 | ||
| Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. | Q42207663 | ||
| Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. | Q42281692 | ||
| Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models. | Q42545193 | ||
| p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells | Q42716243 | ||
| Oxidative stress in very low birth weight infants as measured by urinary 8-OHdG. | Q43985458 | ||
| Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice | Q44880248 | ||
| Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. | Q47991283 | ||
| A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer | Q48225584 | ||
| Trends in childhood cancer incidence in the U.S. (1992-2004). | Q51111080 | ||
| Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis. | Q51768533 | ||
| Activated NOTCH2 is overexpressed in hepatoblastomas: an immunohistochemical study. | Q51865266 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 16 | |
| P921 | main subject | hepatoblastoma | Q1607658 |
| P304 | page(s) | e88549 | |
| P577 | publication date | 2016-10-06 | |
| P1433 | published in | JCI insight | Q27727187 |
| P1476 | title | Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin | |
| P478 | volume | 1 |
| Q92922103 | Animal Modeling of Pediatric Liver Cancer |
| Q64105137 | Emergence of the Dedifferentiated Phenotype in Hepatocyte-Derived Tumors in Mice: Roles of Oncogene-Induced Epigenetic Alterations |
| Q97426639 | Hepatoblastoma: current knowledge and promises from preclinical studies |
| Q41670848 | Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells |
| Q50207061 | Molecular classification of hepatoblastoma and prognostic value of the HB 16-gene signature. |
| Q91791204 | Nrf1 Is Endowed with a Dominant Tumor-Repressing Effect onto the Wnt/β-Catenin-Dependent and Wnt/β-Catenin-Independent Signaling Networks in the Human Liver Cancer |
| Q90227916 | The Emerging Roles of Cancer Stem Cells and Wnt/Beta-Catenin Signaling in Hepatoblastoma |
| Q33608524 | c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease. |
Search more.